We therefore used a genetic knockout of ADAM10, from U251 GBM cells by CRISPR/Cas9, to investigate the resulting changes in protein shedding, protein expression, the proliferation of cells in vitro, and tumour xenografts in mice. The gene discussed is ADAM10; the disease is glioblastoma.